drugset
drugset / Trial / NCT00912639

A Clinical Trial of Paclitaxel Loaded Polymeric Micelle in Patients With Taxane-Pretreated Recurrent Breast Cancer

NCT00912639 ↗

Phase 4 Unknown 90 enrolled Korean Breast Cancer Study Group
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the response rate in patients with taxane-pretreated recurrent breast cancer receiving paclitaxel loaded polymeric micelle (Genexol-PM).

Timeline

Start
2009-05
Primary completion
2010-05
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Paclitaxel Small molecule 300 mg/m2 Intravenous

Indications

breast carcinoma